Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation

Liver Transplantation

Volumn 8, Issue 3, 2002, Pages 224-232

  Trull, Andrew ^a   Hughes, Victoria ^a   Cooper, Dawn ^a   Wilkins, Matthew ^a   Gimson, Alexander ^a   Friend, Peter ^b   Johnston, Atholl ^c   Sharples, Linda ^d   Park, Gilbert ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; GELATIN SUCCINATE; HUMAN ALBUMIN; HUMAN SERUM ALBUMIN; PHENAZONE; PREDNISOLONE; TACROLIMUS;

ADULT; AGITATION; ARTICLE; BRAIN DISEASE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEPRESSION; DIET SUPPLEMENTATION; DISORIENTATION; DRUG EFFICACY; DRUG PROTEIN BINDING; FEMALE; GRAFT REJECTION; HALLUCINATION; HEADACHE; HUMAN; HYPOALBUMINEMIA; INSOMNIA; LIVER CIRRHOSIS; LIVER CLEARANCE; LIVER DYSFUNCTION; LIVER METABOLISM; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SEIZURE; SIDE EFFECT; TREMOR; VERTIGO;

EID: 0036196934     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.31347     Document Type: Article

References (25)

1. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials
2. Molecular mechanisms of drug metabolism in the critically ill
3. Distribution of FK506 in plasma lipoproteins in transplant patients
4. Studiess on non-covalent associations of immunosuppressive drugs with serum albumin using pneumatically assisted electrospray ionization mass spectrometry
5. The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant recipients
6. Influence of protein binding and use of unbound (free) drug concentrations. Principles of therapeutic drug monitoring
7. Disposition of TAC (FK506) in rabbits. Role of red blood cell binding in hepatic clearance
8. Pharmacokinetics of cyclosporin in heart and lung transplant candidates and recipients with cystic fibrosis and Eisenmenger's syndrome
9. Pharmacokinetic interpretation of FK506 levels in blood and plasma during a European randomised study in primary liver transplant patients
10. Prednisone side-effects and serum-protein levels
11. Diphenylhydantoin side-effects and serum albumin levels
12. Clinical toxicity of chlordiazepoxide and diazepam in relation to serum albumin concentration: A report from BCDSP
13. Influence of acute viral hepatitis on phenytoin kinetics and protein binding
14. Effect of hepatic dysfunction and T-tube clamping on FK506 pharmacokinetics
15. Theophylline disposition in patients with hepatic cirrhosis
16. Neurotoxicity after orthotopic liver transplantation
17. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
18. Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion
19. Markers of cerebral ischemia after cardiac surgery
20. Management of minor head injury: The value of early computed tomography and serum protein S-100 measurements
21. Accuracy and clinical utility of simplified tests of antipyrine metabolism
22. Pathology of liver transplantation. Liver, biliary tract and exocrine pancreas
23. Cyclosporine levels in the early posttransplant period-Predictive of chronic rejection in liver transplantation?
24. Quantifying hepatic dysfunction in the presence of liver disease with phenazone (antipyrine) and its metabolites
25. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome